ENTITY

Tg Therapeutics (TGTX US)

2
Analysis
Health CareUnited States
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.
more
Company Event27 Feb 2026 22:30 • Upcoming
Add To Calendar
Company Event03 Dec 2025 01:30 • Latest
Company Event12 Nov 2025 23:00
Company Event03 Nov 2025 21:30
Company Event04 Aug 2025 20:30
x